Welcome to Advanced Search

B16-F1

Strain Name：B16-F1
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-S33A

B16-F1 is a murine cell line of melanoma, which was derived from the pulmonary melanoma nodule from the first serial passage of B16-F0 parent cell line in C57BL/6 mice.

B16-F0

Strain Name：B16-F0
Strain State ： Validation of tumorigenic capacity |  Cat. NO.：NM-S32A

Mouse skin cancer cell line

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

F0 homozygous mice gene knockout Crispr/Cas projects immediate phenotype analysis research efficiency cost optimization.

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Genotyping method for CRISPR/Cas9 point mutation mouse

Genotyping method for CRISPR/Cas9 Knockout mouse

Gene Knockout

gene knockout gene knockout technology knockout mice

Expedite your research with highly customizable, gene knockout mouse models that provide thorough insight into key genetic mechanisms.

Overview of gene editing technology

gene editing crispr gene editing gene editing technology

Liver Cancer PDX Model

PDX PDX models Patient-derived Xenografts

Patient-derived Xenografts (PDX) are advanced preclinical oncology models for drug development. It offers a far better alternative for preclinical drug evaluation as compared to the conventional cell line-derived xenograft model.